NetworkNewsBreaks Archive - Page 128 of 2117

MondayJul 28, 2025 10:34 am

NetworkNewsBreaks – HealthLynked Corp. (OTCQB: HLYK) Launches Enterprise Healthcare Solutions Website and Upgrades Provider Directory

HealthLynked (OTCQB: HLYK), a pioneer in healthcare technology and patient engagement, announced the launch of its newly designed Enterprise Healthcare Solutions Website, www.hlykgroup.com, and significant enhancements to its national provider directory. The new platform serves as a centralized hub for insurance carriers, pharmaceutical companies, marketing firms, ACOs, healthcare networks, and large employers, offering tools for patient engagement, population health, clinical research, coordinated care, and cost management. Upgrades to the consumer-facing provider directory include faster performance and localized provider suggestions, giving patients improved flexibility and transparency in selecting care. CEO Dr. Michael Dent said the developments reflect HealthLynked’s expanding role in…

MondayJul 28, 2025 9:45 am

NetworkNewsBreaks – Bollinger Innovations, Inc. (NASDAQ: BINI) Completes Name and Ticker Change from Mullen Automotive

Bollinger Innovations (NASDAQ: BINI), an electric vehicle manufacturer, announced that its previously disclosed name change from Mullen Automotive Inc. to Bollinger Innovations, Inc. is effective as of July 28, 2025, along with its new Nasdaq stock symbol “BINI.” The company stated the transition unifies its commercial Class 1, 3 and 4 vehicles under a single brand identity. CEO and Chairman David Michery said the move marks the completion of the company’s brand evolution while having no impact on its legal structure or operations. No shareholder action is required as a result of the changes. To view the full press release,…

MondayJul 28, 2025 9:00 am

NetworkNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Appoints Dr. Lee T. Schalop to Board to Bolster AI-Driven Precision Oncology

Lantern Pharma (NASDAQ: LTRN), a clinical-stage biopharmaceutical company leveraging artificial intelligence and genomic data to accelerate oncology drug discovery, announced the appointment of Lee T. Schalop, MD, to its Board of Directors. Dr. Schalop, co-founder and former CEO of Oncoceutics Inc., brings over 20 years of experience in biotechnology leadership and financial markets, with a track record in developing targeted therapies for solid tumors, including HK327M-mutant gliomas. Oncoceutics was acquired by Chimerix Inc. (NASDAQ: CMRX) for $450 million in 2021 and later by Jazz Pharmaceuticals for $935 million in April 2025. Lantern CEO Panna Sharma said Dr. Schalop’s expertise in…

FridayJul 25, 2025 3:38 pm

NetworkNewsBreaks – Nicola Mining Inc. (TSX.V: NIM) (OTCQB: HUSIF) Poised for Steady Production, Long-Term Success in British Columbia

Amid the rising value of precious metals, Nicola Mining (TSX.V: NIM) (OTCQB: HUSIF) began processing high-grade gold and silver ore at its Merritt Mill facility, highlighting a key step forward in its growth. “Nicola expects to cumulatively process 60,000 (tn) of ore and produce 21,000 (oz) of gold-equivalent concentrate at full production capacity annual rate. The Merritt Mill provides accessible, reliable revenue to not only its British Columbian partners, but it also sustains its own copper, gold and silver projects across the province,” reads a recent article. “We are excited to realize that Nicola is morphing into a steady and…

FridayJul 25, 2025 3:29 pm

NetworkNewsBreaks – Ucore Rare Metals Inc.’s (TSX.V: UCU) (OTCQX: UURAF) RapidSX(TM) Core to Blueprint to Secure Rare Earth Independence

Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) is positioned as a key player in a strategy to build a secure, independent rare earth supply chain in North America. Triggered by China’s export restrictions on key elements, a potential blueprint includes diversifying rare earth sources, using modular refining with Ucore’s RapidSX(TM) technology, anchoring refining with magnet-making hubs, establishing stockpiles and off-take agreements, and proving the chain with traceability and ESG standards. Ucore’s RapidSX(TM) is central to reducing bottlenecks in chemical separation, helping to develop a resilient, transparent, and strategically independent supply chain. To view the full article, visit https://nnw.fm/FFmqw About Ucore…

FridayJul 25, 2025 3:28 pm

NetworkNewsBreaks – Targeting the Unmet: Soligenix Inc. (NASDAQ: SNGX) Building Portfolio for Rare Conditions

According to a recent article, “Behçet’s disease is rare, with prevalence estimates varying from 0.12 to 7.5 per 100,000 in the United States and Europe… Behçet’s disease is believed to be an autoimmune illness with both genetic and environmental components. Symptoms are most severe in young adulthood and generally ameliorate with age… Treatment involves medications designed to ease symptoms and prevent serious complications, such as blindness. Even with treatment, oral and genital flares can continue to occur for many patients and significantly affect quality of life and productivity. In addition, treatments can be associated with adverse effects, underscoring the need…

FridayJul 25, 2025 3:18 pm

NetworkNewsBreaks – Nutriband Inc. (NASDAQ: NTRB): Innovation Meets Science Through Scalable Platform

Nutriband (NASDAQ: NTRB) is positioning at the forefront of abuse-deterrent drug delivery in advancing its flagship fentanyl patch and buprenorphine candidates. The company combines transdermal innovation with abuse-deterrent science to meet critical public health needs. According to Nurtiband, AVERSA Fentanyl, with the possibility to reach peak annual U.S. sales of $80 to $200 million, holds the potential to be the world’s first opioid patch designed to deter the abuse and misuse and reduce the risk of accidental exposure of transdermal fentanyl patches. In addition, Nutriband is advancing AVERSA Buprenorphine, which upon approval is projected to achieve peak U.S. sales between…

FridayJul 25, 2025 3:10 pm

NetworkNewsBreaks – Clene Inc. (NASDAQ: CLNN) Builds Momentum to Bring New Hope to Neuro Patients

Clene (NASDAQ: CLNN), together with its subsidiary Clene Nanomedicine Inc., is preparing to initiate neurofilament biomarker analyses for its lead drug candidate CNM-Au8(R) in ALS, following feedback from the FDA during a recent Type C meeting. Slated for early Q4 2025, the analyses will assess changes in neurofilament light chain (“NfL”)—a recognized marker for neurodegeneration—among nearly 200 patients treated through the Expanded Access Program for CNM-Au8. “We are encouraged by the FDA’s collaborative approach and their constructive feedback on our NfL biomarker analysis plan from the ongoing NIH-sponsored EAP program,” said Benjamin Greenberg, MD, Head of Medical at Clene. “With…

FridayJul 25, 2025 9:00 am

NetworkNewsBreaks – LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) Spotlights Gold Strategy and Mill Acquisition on MiningNewsWire Podcast

LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0), a Canadian gold exploration and development company, is featured on the latest episode of The MiningNewsWire Podcast hosted by IBN. Chairman Kal Malhi and CEO Paul Ténière detail the company’s positioning as a near-term producer in Québec’s Abitibi Gold Belt, emphasizing its advanced Swanson Gold Project and fully permitted Beacon Mill. Malhi discusses acquiring the mill through a strategic bankruptcy bid, while Ténière highlights the company’s fast-track production path amid rising gold prices and growing regional opportunity. To view the full press release, visit https://nnw.fm/4ioYI About LaFleur Minerals Inc. LaFleur Minerals Inc.…

ThursdayJul 24, 2025 3:56 pm

NetworkNewsBreaks – ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Seismic Imaging and Academic Studies Support Broken Hill-Type Analogue at Montauban

ESGold (CSE: ESAU) (OTCQB: ESAUF) has announced results from its Ambient Noise Tomography (ANT) survey that validate earlier academic comparisons between its Montauban Gold-Silver Project and the globally significant Broken Hill deposit in Australia. Seismic imaging confirmed mineralized zones down to 1,200 metres, reinforcing a vertically stacked model previously described in peer-reviewed research from the University of Calgary and University of British Columbia. The studies identify sulphide melting, hydrothermal activity, and structural deformation as key remobilization mechanisms for precious metals—findings now echoed by ESGold’s deep geophysical data. The Montauban project is being repositioned as a complex, multi-lens system with district-scale…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks